LD1100

Clarifies drug coverage requirements for nonformulary drugs and drugs used to treat serious mental illness in Maine.

This bill amends Maine law to clarify that if a drug shortage causes a formulary drug prescribed to assess or treat an enrollee's serious mental illness to become unavailable, the carrier must approve an equivalent nonformulary drug for the period of time that the formulary drug is unavailable. The carrier must also have a process by which an expedited review may be requested in exigent circumstances, such as when an enrollee is suffering from a health condition that may seriously jeopardize their life, health, or ability to regain maximum function.